vs

Side-by-side financial comparison of Riley Exploration Permian, Inc. (REPX) and Schrodinger, Inc. (SDGR). Click either name above to swap in a different company.

Riley Exploration Permian, Inc. is the larger business by last-quarter revenue ($97.3M vs $87.2M, roughly 1.1× Schrodinger, Inc.). On growth, Schrodinger, Inc. posted the faster year-over-year revenue change (-1.2% vs -5.3%). Over the past eight quarters, Schrodinger, Inc.'s revenue compounded faster (54.4% CAGR vs -1.2%).

Riley Exploration Permian, Inc. is an independent energy company focused on exploration, development, and production of crude oil, natural gas, and natural gas liquids primarily in the US Permian Basin spanning Texas and New Mexico. It prioritizes cost-efficient onshore reserve development to supply reliable energy products to North American markets.

Schrodinger, Inc. is a leading provider of advanced computational chemistry and physics software platforms, along with related consulting services, focused on accelerating drug discovery and novel materials development. Its solutions are adopted by biopharmaceutical companies, chemical manufacturers, academic research institutions and government entities across North America, Europe and Asia Pacific to cut R&D costs and shorten innovation cycles.

REPX vs SDGR — Head-to-Head

Bigger by revenue
REPX
REPX
1.1× larger
REPX
$97.3M
$87.2M
SDGR
Growing faster (revenue YoY)
SDGR
SDGR
+4.1% gap
SDGR
-1.2%
-5.3%
REPX
Faster 2-yr revenue CAGR
SDGR
SDGR
Annualised
SDGR
54.4%
-1.2%
REPX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
REPX
REPX
SDGR
SDGR
Revenue
$97.3M
$87.2M
Net Profit
$32.5M
Gross Margin
65.7%
Operating Margin
26.9%
-19.7%
Net Margin
37.3%
Revenue YoY
-5.3%
-1.2%
Net Profit YoY
180.8%
EPS (diluted)
$4.02
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
REPX
REPX
SDGR
SDGR
Q4 25
$97.3M
$87.2M
Q3 25
$106.9M
$54.3M
Q2 25
$85.4M
$54.8M
Q1 25
$102.5M
$59.6M
Q4 24
$102.7M
$88.3M
Q3 24
$102.3M
$35.3M
Q2 24
$105.4M
$47.3M
Q1 24
$99.7M
$36.6M
Net Profit
REPX
REPX
SDGR
SDGR
Q4 25
$32.5M
Q3 25
$16.3M
$-32.8M
Q2 25
$30.5M
$-43.2M
Q1 25
$28.6M
$-59.8M
Q4 24
$-40.2M
Q3 24
$25.7M
$-38.1M
Q2 24
$33.5M
$-54.0M
Q1 24
$18.8M
$-54.7M
Gross Margin
REPX
REPX
SDGR
SDGR
Q4 25
65.7%
Q3 25
51.6%
Q2 25
47.8%
Q1 25
52.3%
Q4 24
72.6%
Q3 24
50.2%
Q2 24
66.2%
Q1 24
51.6%
Operating Margin
REPX
REPX
SDGR
SDGR
Q4 25
26.9%
-19.7%
Q3 25
27.0%
-84.6%
Q2 25
33.7%
-96.6%
Q1 25
48.3%
-85.5%
Q4 24
31.2%
-23.5%
Q3 24
17.1%
-193.9%
Q2 24
50.9%
-111.4%
Q1 24
50.7%
-184.3%
Net Margin
REPX
REPX
SDGR
SDGR
Q4 25
37.3%
Q3 25
15.3%
-60.4%
Q2 25
35.7%
-78.8%
Q1 25
27.9%
-100.4%
Q4 24
-45.5%
Q3 24
25.1%
-108.1%
Q2 24
31.8%
-114.2%
Q1 24
18.8%
-149.5%
EPS (diluted)
REPX
REPX
SDGR
SDGR
Q4 25
$4.02
$0.45
Q3 25
$0.77
$-0.45
Q2 25
$1.44
$-0.59
Q1 25
$1.36
$-0.82
Q4 24
$0.52
$-0.55
Q3 24
$1.21
$-0.52
Q2 24
$1.59
$-0.74
Q1 24
$0.94
$-0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
REPX
REPX
SDGR
SDGR
Cash + ST InvestmentsLiquidity on hand
$395.5M
Total DebtLower is stronger
$247.9M
Stockholders' EquityBook value
$634.2M
$364.1M
Total Assets
$1.2B
$726.2M
Debt / EquityLower = less leverage
0.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
REPX
REPX
SDGR
SDGR
Q4 25
$395.5M
Q3 25
$391.2M
Q2 25
$450.2M
Q1 25
$500.3M
Q4 24
$352.1M
Q3 24
$388.7M
Q2 24
$377.3M
Q1 24
$431.1M
Total Debt
REPX
REPX
SDGR
SDGR
Q4 25
$247.9M
Q3 25
$367.0M
Q2 25
$275.2M
Q1 25
$249.3M
Q4 24
$269.5M
Q3 24
$288.6M
Q2 24
$322.7M
Q1 24
$341.8M
Stockholders' Equity
REPX
REPX
SDGR
SDGR
Q4 25
$634.2M
$364.1M
Q3 25
$566.5M
$321.4M
Q2 25
$556.9M
$342.9M
Q1 25
$532.4M
$373.5M
Q4 24
$510.6M
$421.4M
Q3 24
$507.4M
$449.4M
Q2 24
$489.0M
$474.0M
Q1 24
$434.6M
$513.7M
Total Assets
REPX
REPX
SDGR
SDGR
Q4 25
$1.2B
$726.2M
Q3 25
$1.2B
$653.7M
Q2 25
$1.0B
$688.2M
Q1 25
$994.9M
$743.0M
Q4 24
$993.5M
$823.2M
Q3 24
$997.9M
$669.3M
Q2 24
$1.0B
$688.4M
Q1 24
$956.4M
$737.8M
Debt / Equity
REPX
REPX
SDGR
SDGR
Q4 25
0.39×
Q3 25
0.65×
Q2 25
0.49×
Q1 25
0.47×
Q4 24
0.53×
Q3 24
0.57×
Q2 24
0.66×
Q1 24
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
REPX
REPX
SDGR
SDGR
Operating Cash FlowLast quarter
$64.9M
$-16.1M
Free Cash FlowOCF − Capex
$-16.1M
FCF MarginFCF / Revenue
-18.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
REPX
REPX
SDGR
SDGR
Q4 25
$64.9M
$-16.1M
Q3 25
$63.6M
$-61.9M
Q2 25
$33.6M
$-52.2M
Q1 25
$50.4M
$144.1M
Q4 24
$66.4M
$-31.1M
Q3 24
$72.1M
$-33.3M
Q2 24
$51.6M
$-53.7M
Q1 24
$56.1M
$-39.3M
Free Cash Flow
REPX
REPX
SDGR
SDGR
Q4 25
$-16.1M
Q3 25
$-62.4M
Q2 25
$-52.5M
Q1 25
$143.5M
Q4 24
$-32.0M
Q3 24
$-34.6M
Q2 24
$-54.7M
Q1 24
$-43.4M
FCF Margin
REPX
REPX
SDGR
SDGR
Q4 25
-18.5%
Q3 25
-114.8%
Q2 25
-95.9%
Q1 25
240.9%
Q4 24
-36.2%
Q3 24
-98.0%
Q2 24
-115.6%
Q1 24
-118.5%
Capex Intensity
REPX
REPX
SDGR
SDGR
Q4 25
0.0%
Q3 25
0.9%
Q2 25
0.6%
Q1 25
1.0%
Q4 24
1.0%
Q3 24
3.8%
Q2 24
2.1%
Q1 24
11.2%
Cash Conversion
REPX
REPX
SDGR
SDGR
Q4 25
-0.50×
Q3 25
3.90×
Q2 25
1.10×
Q1 25
1.76×
Q4 24
Q3 24
2.81×
Q2 24
1.54×
Q1 24
2.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

REPX
REPX

Segment breakdown not available.

SDGR
SDGR

On Premise Software$44.4M51%
Drug Discovery Services$17.6M20%
Hosted Software$11.5M13%
Maintenance$6.9M8%
Professional Services$3.8M4%
July2024Agreement With Bill Melinda Gates Foundation$2.7M3%

Related Comparisons